{
  "source": "Nasdaq Nordic Company News",
  "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
  "status": "retrieved",
  "company": "SynAct Pharma AB",
  "reports": [
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:22Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q1 2026",
      "category": "Interimsrapport",
      "date": "2026-05-27",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2026,
      "quarter": "q1",
      "period": "2026-q1",
      "report_key": "2026:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b4dbd3f271989f587de7c9243c1fc78e8&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q1 2026 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/aef628bb051762f152807cda4a5c133c9",
          "final_url": "https://attachment.news.eu.nasdaq.com/aef628bb051762f152807cda4a5c133c9",
          "filename": "SynAct_Pharma_Q1_2026_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\SynAct_Pharma_Q1_2026_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 9871490,
          "sha256": "2e857f4d02c1d3a9483800a2d9b775729fff9fed9ee497f0973f7e87322e4b97",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\SynAct_Pharma_Q1_2026_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q1_2026_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 9871490,
            "sha256": "2e857f4d02c1d3a9483800a2d9b775729fff9fed9ee497f0973f7e87322e4b97",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\SynAct_Pharma_Q1_2026_Delarsrapport\\SynAct_Pharma_Q1_2026_Delarsrapport.txt",
            "text_chars": 89833,
            "metadata": {
              "page_count": 34,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\SynAct_Pharma_Q1_2026_Delarsrapport\\SynAct_Pharma_Q1_2026_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1444481",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:33Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar årsredovisning för 2025",
      "category": "Bokslut och Verksamhetsberättelse",
      "date": "2026-04-15",
      "language": "sv",
      "report_type": "annual-report",
      "fiscal_year": 2025,
      "quarter": "annual",
      "period": "2025-annual",
      "report_key": "2025:annual",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b6a5a1ede73128c3217fb82c7e1b9a1cf&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma AB Arsredovisning 2025.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a459e70f487d42df785c6bb5c7faf489a",
          "final_url": "https://attachment.news.eu.nasdaq.com/a459e70f487d42df785c6bb5c7faf489a",
          "filename": "SynAct_Pharma_AB_Arsredovisning_2025.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\SynAct_Pharma_AB_Arsredovisning_2025.pdf",
          "content_type": "application/pdf",
          "size": 10188729,
          "sha256": "990b1b3dd10a421ca68244074ce2aef48d441b54944c9d912f57803bcc3c6e91",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\SynAct_Pharma_AB_Arsredovisning_2025.pdf",
            "filename": "SynAct_Pharma_AB_Arsredovisning_2025.pdf",
            "extension": ".pdf",
            "size": 10188729,
            "sha256": "990b1b3dd10a421ca68244074ce2aef48d441b54944c9d912f57803bcc3c6e91",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2025\\SynAct_Pharma_AB_Arsredovisning_2025.txt",
            "text_chars": 285170,
            "metadata": {
              "page_count": 79,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2025\\SynAct_Pharma_AB_Arsredovisning_2025.extraction.json"
          }
        }
      ],
      "announcement_id": "1434528",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:37Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma bokslutskommuniké för 2025",
      "category": "Bokslutskommuniké",
      "date": "2026-02-18",
      "language": "sv",
      "report_type": "year-end-report",
      "fiscal_year": 2025,
      "quarter": "q4",
      "period": "2025-q4",
      "report_key": "2025:q4",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bc31286864fea797564f598cedd475419&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q4 2025 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/aacfe3c91766da9d853ef2d782fed5c73",
          "final_url": "https://attachment.news.eu.nasdaq.com/aacfe3c91766da9d853ef2d782fed5c73",
          "filename": "SynAct_Pharma_Q4_2025_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\SynAct_Pharma_Q4_2025_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 2533435,
          "sha256": "2b486bd51ce23ff281f5af5b5a73213867292be738267531cfc10cf2bf1f5de1",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\SynAct_Pharma_Q4_2025_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q4_2025_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 2533435,
            "sha256": "2b486bd51ce23ff281f5af5b5a73213867292be738267531cfc10cf2bf1f5de1",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\SynAct_Pharma_Q4_2025_Delarsrapport\\SynAct_Pharma_Q4_2025_Delarsrapport.txt",
            "text_chars": 90669,
            "metadata": {
              "page_count": 31,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\SynAct_Pharma_Q4_2025_Delarsrapport\\SynAct_Pharma_Q4_2025_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1420866",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:42Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q3 2025",
      "category": "Interimsrapport",
      "date": "2025-10-30",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q3",
      "period": "2025-q3",
      "report_key": "2025:q3",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b7b6fd4c4508279a30ae185e81bf1b6b5&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q3 2025 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a9aa6754168c9d211bb79cf0bd9ea3c4e",
          "final_url": "https://attachment.news.eu.nasdaq.com/a9aa6754168c9d211bb79cf0bd9ea3c4e",
          "filename": "SynAct_Pharma_Q3_2025_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\SynAct_Pharma_Q3_2025_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 2543671,
          "sha256": "334a266722ca6536cd1fa365a15bbb2bae489b22f558e145500792e705e29151",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\SynAct_Pharma_Q3_2025_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q3_2025_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 2543671,
            "sha256": "334a266722ca6536cd1fa365a15bbb2bae489b22f558e145500792e705e29151",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\SynAct_Pharma_Q3_2025_Delarsrapport\\SynAct_Pharma_Q3_2025_Delarsrapport.txt",
            "text_chars": 89961,
            "metadata": {
              "page_count": 31,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\SynAct_Pharma_Q3_2025_Delarsrapport\\SynAct_Pharma_Q3_2025_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1397544",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:48Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q2 2025",
      "category": "Halvårsrapport",
      "date": "2025-08-20",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q2",
      "period": "2025-q2",
      "report_key": "2025:q2",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b90dc6f2e84323bd7f31e7974e18f0898&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q2 2025 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/abb85308bea260d076ba2c5c4f3950960",
          "final_url": "https://attachment.news.eu.nasdaq.com/abb85308bea260d076ba2c5c4f3950960",
          "filename": "SynAct_Pharma_Q2_2025_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\SynAct_Pharma_Q2_2025_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 6931406,
          "sha256": "89acc586725d0dc585547f14d032093321e136369e5576f1b9bdb89a7d394660",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\SynAct_Pharma_Q2_2025_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q2_2025_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 6931406,
            "sha256": "89acc586725d0dc585547f14d032093321e136369e5576f1b9bdb89a7d394660",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\SynAct_Pharma_Q2_2025_Delarsrapport\\SynAct_Pharma_Q2_2025_Delarsrapport.txt",
            "text_chars": 85186,
            "metadata": {
              "page_count": 31,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\SynAct_Pharma_Q2_2025_Delarsrapport\\SynAct_Pharma_Q2_2025_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1384160",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:52Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q1 2025",
      "category": "Interimsrapport",
      "date": "2025-05-27",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q1",
      "period": "2025-q1",
      "report_key": "2025:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=ba8ac9ab3446edc51940e263080806c03&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q1 2025 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/af03394fd18f44f9f7460b90bb573c281",
          "final_url": "https://attachment.news.eu.nasdaq.com/af03394fd18f44f9f7460b90bb573c281",
          "filename": "SynAct_Pharma_Q1_2025_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\SynAct_Pharma_Q1_2025_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 2506323,
          "sha256": "f7fbf9bd26e12ccbb00005fd5f31a781c88390c9b399700675a1767f6b0fb6a2",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\SynAct_Pharma_Q1_2025_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q1_2025_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 2506323,
            "sha256": "f7fbf9bd26e12ccbb00005fd5f31a781c88390c9b399700675a1767f6b0fb6a2",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\SynAct_Pharma_Q1_2025_Delarsrapport\\SynAct_Pharma_Q1_2025_Delarsrapport.txt",
            "text_chars": 79745,
            "metadata": {
              "page_count": 31,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\SynAct_Pharma_Q1_2025_Delarsrapport\\SynAct_Pharma_Q1_2025_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1365807",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:02:59Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar årsredovisning för 2024",
      "category": "Bokslut och Verksamhetsberättelse",
      "date": "2025-04-10",
      "language": "sv",
      "report_type": "annual-report",
      "fiscal_year": 2024,
      "quarter": "annual",
      "period": "2024-annual",
      "report_key": "2024:annual",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b1214e81951fde15c9da3d2bcf8be9b16&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma AB Arsredovisning 2024.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a55291ac91810d4e6b483d2b5b3ff628e",
          "final_url": "https://attachment.news.eu.nasdaq.com/a55291ac91810d4e6b483d2b5b3ff628e",
          "filename": "SynAct_Pharma_AB_Arsredovisning_2024.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\SynAct_Pharma_AB_Arsredovisning_2024.pdf",
          "content_type": "application/pdf",
          "size": 3133731,
          "sha256": "ce15cb2f11cde6b84bb7906187c0d60655e366a6916d188b4d0af5be1d3756ed",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\SynAct_Pharma_AB_Arsredovisning_2024.pdf",
            "filename": "SynAct_Pharma_AB_Arsredovisning_2024.pdf",
            "extension": ".pdf",
            "size": 3133731,
            "sha256": "ce15cb2f11cde6b84bb7906187c0d60655e366a6916d188b4d0af5be1d3756ed",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2024\\SynAct_Pharma_AB_Arsredovisning_2024.txt",
            "text_chars": 280555,
            "metadata": {
              "page_count": 78,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2024\\SynAct_Pharma_AB_Arsredovisning_2024.extraction.json"
          }
        }
      ],
      "announcement_id": "1355340",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:02Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma bokslutskommuniké för 2024",
      "category": "Bokslutskommuniké",
      "date": "2025-02-18",
      "language": "sv",
      "report_type": "year-end-report",
      "fiscal_year": 2024,
      "quarter": "q4",
      "period": "2024-q4",
      "report_key": "2024:q4",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bd249300c7365a92e6482feeacfdc0cab&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q4 2024 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a7244d301ff63415f15fa946cdc137082",
          "final_url": "https://attachment.news.eu.nasdaq.com/a7244d301ff63415f15fa946cdc137082",
          "filename": "SynAct_Pharma_Q4_2024_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\SynAct_Pharma_Q4_2024_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1196574,
          "sha256": "569b64ec4f7fc3bfe36417d573ad58a3909b9b3e69986e46c391cdd9eeb7a0fd",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\SynAct_Pharma_Q4_2024_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q4_2024_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1196574,
            "sha256": "569b64ec4f7fc3bfe36417d573ad58a3909b9b3e69986e46c391cdd9eeb7a0fd",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\SynAct_Pharma_Q4_2024_Delarsrapport\\SynAct_Pharma_Q4_2024_Delarsrapport.txt",
            "text_chars": 77354,
            "metadata": {
              "page_count": 27,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\SynAct_Pharma_Q4_2024_Delarsrapport\\SynAct_Pharma_Q4_2024_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1343613",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:07Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q3 2024",
      "category": "Interimsrapport",
      "date": "2024-10-30",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2024,
      "quarter": "q3",
      "period": "2024-q3",
      "report_key": "2024:q3",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b97d88d92d29c13e7aa9b3d7bf24d8e25&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q3 2024 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a624caea2485d1f24373c8eeaaa8a03be",
          "final_url": "https://attachment.news.eu.nasdaq.com/a624caea2485d1f24373c8eeaaa8a03be",
          "filename": "SynAct_Pharma_Q3_2024_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\SynAct_Pharma_Q3_2024_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1187532,
          "sha256": "7c8a711c3a4d3d8fa874537d61836642f5675e790a2499701709ecbc2640eba7",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\SynAct_Pharma_Q3_2024_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q3_2024_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1187532,
            "sha256": "7c8a711c3a4d3d8fa874537d61836642f5675e790a2499701709ecbc2640eba7",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\SynAct_Pharma_Q3_2024_Delarsrapport\\SynAct_Pharma_Q3_2024_Delarsrapport.txt",
            "text_chars": 76160,
            "metadata": {
              "page_count": 26,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\SynAct_Pharma_Q3_2024_Delarsrapport\\SynAct_Pharma_Q3_2024_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1324458",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:11Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q2 2024",
      "category": "Halvårsrapport",
      "date": "2024-08-20",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2024,
      "quarter": "q2",
      "period": "2024-q2",
      "report_key": "2024:q2",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b1d9932af6f1a16016e700cfcd7b14f9e&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q2 2024 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a9661055a47fa9fd0ca97f5c3119534ca",
          "final_url": "https://attachment.news.eu.nasdaq.com/a9661055a47fa9fd0ca97f5c3119534ca",
          "filename": "SynAct_Pharma_Q2_2024_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\SynAct_Pharma_Q2_2024_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1170065,
          "sha256": "fa27f4242fb3a44034232792f64bf5f3afb3870e46a9daf45c4abca310838a00",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\SynAct_Pharma_Q2_2024_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q2_2024_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1170065,
            "sha256": "fa27f4242fb3a44034232792f64bf5f3afb3870e46a9daf45c4abca310838a00",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\SynAct_Pharma_Q2_2024_Delarsrapport\\SynAct_Pharma_Q2_2024_Delarsrapport.txt",
            "text_chars": 69351,
            "metadata": {
              "page_count": 25,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\SynAct_Pharma_Q2_2024_Delarsrapport\\SynAct_Pharma_Q2_2024_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1311627",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:17Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q1 2024",
      "category": "Interimsrapport",
      "date": "2024-05-31",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2024,
      "quarter": "q1",
      "period": "2024-q1",
      "report_key": "2024:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bddb5d73bca5448c9b63d6c335290d7db&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q1 2024 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/aaf75ad2e30ba61a9470d9cf567dd8be5",
          "final_url": "https://attachment.news.eu.nasdaq.com/aaf75ad2e30ba61a9470d9cf567dd8be5",
          "filename": "SynAct_Pharma_Q1_2024_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\SynAct_Pharma_Q1_2024_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1201475,
          "sha256": "913da495e5a30426e81fae77abcf35d33ce3b31cb011c79aacef0a522670f8f2",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\SynAct_Pharma_Q1_2024_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q1_2024_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1201475,
            "sha256": "913da495e5a30426e81fae77abcf35d33ce3b31cb011c79aacef0a522670f8f2",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\SynAct_Pharma_Q1_2024_Delarsrapport\\SynAct_Pharma_Q1_2024_Delarsrapport.txt",
            "text_chars": 68803,
            "metadata": {
              "page_count": 26,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\SynAct_Pharma_Q1_2024_Delarsrapport\\SynAct_Pharma_Q1_2024_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1299260",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:27Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar årsredovisning för 2023",
      "category": "Bokslut och Verksamhetsberättelse",
      "date": "2024-03-26",
      "language": "sv",
      "report_type": "annual-report",
      "fiscal_year": 2023,
      "quarter": "annual",
      "period": "2023-annual",
      "report_key": "2023:annual",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b65e28271844cd29144b0e0f323241a74&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma AB Arsredovisning 2023.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a1ec65c58dae6cb556634909826df1f8f",
          "final_url": "https://attachment.news.eu.nasdaq.com/a1ec65c58dae6cb556634909826df1f8f",
          "filename": "SynAct_Pharma_AB_Arsredovisning_2023.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\SynAct_Pharma_AB_Arsredovisning_2023.pdf",
          "content_type": "application/pdf",
          "size": 8953847,
          "sha256": "9b266db204f6a3f046d1e162c09a076f94e134618085bb805c9248e197fe3732",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\SynAct_Pharma_AB_Arsredovisning_2023.pdf",
            "filename": "SynAct_Pharma_AB_Arsredovisning_2023.pdf",
            "extension": ".pdf",
            "size": 8953847,
            "sha256": "9b266db204f6a3f046d1e162c09a076f94e134618085bb805c9248e197fe3732",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2023\\SynAct_Pharma_AB_Arsredovisning_2023.txt",
            "text_chars": 293672,
            "metadata": {
              "page_count": 79,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\SynAct_Pharma_AB_Arsredovisning_2023\\SynAct_Pharma_AB_Arsredovisning_2023.extraction.json"
          }
        }
      ],
      "announcement_id": "1283823",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:29Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma AB (publ) (”SynAct”) publicerar idag delårsrapport för det fjärde kvartalet och helåret 2023.",
      "category": "Bokslutskommuniké",
      "date": "2024-02-23",
      "language": "sv",
      "report_type": "year-end-report",
      "fiscal_year": 2023,
      "quarter": "q4",
      "period": "2023-q4",
      "report_key": "2023:q4",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b01eef9f2d05259bf2fb87a11839d9a60&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q4 2023 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a9cf323e4ab27f6b24e4e9b52cd7e85c4",
          "final_url": "https://attachment.news.eu.nasdaq.com/a9cf323e4ab27f6b24e4e9b52cd7e85c4",
          "filename": "SynAct_Pharma_Q4_2023_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\SynAct_Pharma_Q4_2023_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1152408,
          "sha256": "2ab48236d6bcfe24afc35c6544ae3ec7a6b4d2926f084c562312dc86e60efd2c",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\SynAct_Pharma_Q4_2023_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q4_2023_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1152408,
            "sha256": "2ab48236d6bcfe24afc35c6544ae3ec7a6b4d2926f084c562312dc86e60efd2c",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\SynAct_Pharma_Q4_2023_Delarsrapport\\SynAct_Pharma_Q4_2023_Delarsrapport.txt",
            "text_chars": 79563,
            "metadata": {
              "page_count": 27,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\SynAct_Pharma_Q4_2023_Delarsrapport\\SynAct_Pharma_Q4_2023_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1276885",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:35Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q3 2023",
      "category": "Interimsrapport",
      "date": "2023-10-24",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2023,
      "quarter": "q3",
      "period": "2023-q3",
      "report_key": "2023:q3",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b1daab32671cfe3955a09678f5a63dc50&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q3 2023 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a2addd2988ae7f74674ece98ee7708eff",
          "final_url": "https://attachment.news.eu.nasdaq.com/a2addd2988ae7f74674ece98ee7708eff",
          "filename": "SynAct_Pharma_Q3_2023_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\SynAct_Pharma_Q3_2023_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1178175,
          "sha256": "55926ab9c1a78796f8773eced3b263b36a0e3f208958fc49f33948407ae5e0f9",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\SynAct_Pharma_Q3_2023_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q3_2023_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1178175,
            "sha256": "55926ab9c1a78796f8773eced3b263b36a0e3f208958fc49f33948407ae5e0f9",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\SynAct_Pharma_Q3_2023_Delarsrapport\\SynAct_Pharma_Q3_2023_Delarsrapport.txt",
            "text_chars": 81241,
            "metadata": {
              "page_count": 27,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\SynAct_Pharma_Q3_2023_Delarsrapport\\SynAct_Pharma_Q3_2023_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1254215",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:41Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q2 2023",
      "category": "Halvårsrapport",
      "date": "2023-08-04",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2023,
      "quarter": "q2",
      "period": "2023-q2",
      "report_key": "2023:q2",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bbffe932055b30853e88c42b74068e2fa&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q2 2023 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a997d2060d116c6cafbe787ec40bc9d78",
          "final_url": "https://attachment.news.eu.nasdaq.com/a997d2060d116c6cafbe787ec40bc9d78",
          "filename": "SynAct_Pharma_Q2_2023_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\SynAct_Pharma_Q2_2023_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 1156751,
          "sha256": "f701b6dbdd4b13f3b5dc1caa01bfe0b81692fa88b8e68849f05ab2bc51a70c1b",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\SynAct_Pharma_Q2_2023_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q2_2023_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 1156751,
            "sha256": "f701b6dbdd4b13f3b5dc1caa01bfe0b81692fa88b8e68849f05ab2bc51a70c1b",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\SynAct_Pharma_Q2_2023_Delarsrapport\\SynAct_Pharma_Q2_2023_Delarsrapport.txt",
            "text_chars": 79425,
            "metadata": {
              "page_count": 27,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\SynAct_Pharma_Q2_2023_Delarsrapport\\SynAct_Pharma_Q2_2023_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1241138",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T08:03:45Z",
      "company": "SynAct Pharma AB",
      "title": "SynAct Pharma publicerar delårsrapport Q1 2023",
      "category": "Interimsrapport",
      "date": "2023-05-05",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2023,
      "quarter": "q1",
      "period": "2023-q1",
      "report_key": "2023:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b5d5fd93f70f6245f363ac48eb576df2c&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\release.txt",
      "attachments": [
        {
          "label": "SynAct Pharma Q1 2023 Delarsrapport.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a567fdc9793be18c6b909ff87e1934bf6",
          "final_url": "https://attachment.news.eu.nasdaq.com/a567fdc9793be18c6b909ff87e1934bf6",
          "filename": "SynAct_Pharma_Q1_2023_Delarsrapport.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\SynAct_Pharma_Q1_2023_Delarsrapport.pdf",
          "content_type": "application/pdf",
          "size": 3165301,
          "sha256": "57add4595e5fa405563d3c5e30f444197bdef62aeb4b8ba1fc6cd3f6f6e78407",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\SynAct_Pharma_Q1_2023_Delarsrapport.pdf",
            "filename": "SynAct_Pharma_Q1_2023_Delarsrapport.pdf",
            "extension": ".pdf",
            "size": 3165301,
            "sha256": "57add4595e5fa405563d3c5e30f444197bdef62aeb4b8ba1fc6cd3f6f6e78407",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\SynAct_Pharma_Q1_2023_Delarsrapport\\SynAct_Pharma_Q1_2023_Delarsrapport.txt",
            "text_chars": 82787,
            "metadata": {
              "page_count": 29,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\synact-pharma-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\SynAct_Pharma_Q1_2023_Delarsrapport\\SynAct_Pharma_Q1_2023_Delarsrapport.extraction.json"
          }
        }
      ],
      "announcement_id": "1225747",
      "status": "retrieved"
    }
  ],
  "attempts": [
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "45e7ce0021686d96cac6ee9119c3f0c6ede9fc4664da4bb0390e2445c22683a3"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 77,
      "new_rows": 77,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "ace35ab337545d49bc220cf5986f0bd4ddfffc2aa102f697014ac9a799e2393d"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=177&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 177,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "795808c85699c2816992effb6c5056271d95af548e9272d93c7c547c81d769e8"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 4,
      "new_rows": 4,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "b574a45ea5bcee803a0286c0b75231e638440ac8c663cd5cb2b9010a37ad22ea"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=4&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 4,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "e27b60cb74ad0e336cee9c3aa3436314395a27959baa132e37b1113a29192eb8"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "d59574abca50cf4ecf83ad73779a5dfd8f4a06cf8c7c4d44e0ea51f41123eac0"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 76,
      "new_rows": 76,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "ce69564b4ca1054834ad3b974d077f85fd6b96a66f363fff0be90caabdf7517b"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=176&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 176,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "e15cc08dc6a96be458a456b6f8c83963c5650b5d940fdd1cd3cf6dd973a85fa1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 3,
      "new_rows": 3,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "133fcdf7a0516d491756aa487bdba873a7291a2371ad9d9f6101fff4f60f3570"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=SynAct+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=3&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 3,
      "pagination": "row-offset",
      "query_text": "SynAct Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "449de37c3458e07fa7a04e480e0ef1298d825283b8c7f36964108a8672015b9a"
    }
  ],
  "identity": {
    "slug": "",
    "instrument_id": "TX4479212",
    "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/synact?id=TX4479212"
  },
  "transport": "ordinary-http",
  "browser_used": false,
  "query_text": "SynAct Pharma",
  "retrieved_at": "2026-08-07T08:03:46Z"
}